Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases
Author:
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Link
https://link.springer.com/content/pdf/10.1007/s00281-022-00925-9.pdf
Reference74 articles.
1. Boycott KM, Ardigó D (2018) Addressing challenges in the diagnosis and treatment of rare genetic diseases. Nat Rev Drug Discovery 17:151–152
2. Dawkins HJS, Draghia-Akli R, Lasko P, Lau LPL, Jonker AH, Cutillo CM, Rath A, Boycott KM, Baynam G, Lochmüller H, Kaufmann P, Le Cam Y, Hivert V, Austin CP (2018) Progress in rare diseases research 2010–2016: an IRDiRC perspective. Clin Transl Sci 11:11–20
3. Savoji H, Mohammadi MH, Rafatian N, Toroghi MK, Wang EY, Zhao Y, Korolj A, Ahadian S, Radisic M (2019) Cardiovascular disease models: a game changing paradigm in drug discovery and screening. Biomaterials 198:3–26
4. Mensah GA, Roth GA, Fuster V (2019) The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 74:2529–2532
5. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E et al (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76:2982–3021
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revolutionizing vascular health through the temporal convolutional transformer for drug screening and model evolution;Biomedical Signal Processing and Control;2024-09
2. Review: Human stem cell-based 3D in vitro angiogenesis models for preclinical drug screening applications;Molecular Biology Reports;2024-02-01
3. Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling;Expert Opinion on Drug Discovery;2023-12-20
4. Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy;Seminars in Immunopathology;2022-05
5. PBAT/gelatin hybrid nanofibers based on post-double network bond processing as a promising vascular substitute;RSC Advances;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3